ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Bristol-Myers Squibb Company (BMY) shows an Average True Range (ATR) of 1.3 and an Enterprise Value of 129.03B. Its average trading volume over the past 3 months is 14.26M, indicating liquidity. These fundamental metrics provide insight into BMY's underlying financial health and market activity.
Bristol-Myers Squibb Company (BMY) technical indicators as of August 1, 2025: the SMA 20 is -8.3%, SMA 50 at -8.96%, and SMA 200 at -19.28%. The RSI 14 value is 31.96, suggesting its current momentum. These technical analysis signals help assess BMY's price trends and potential future movements.
Bristol-Myers Squibb Company (BMY) stock performance overview as of August 1, 2025: The 52-week high is $63.33 (currently -31.61% below), and the 52-week low is $42.96 (currently -1.57% above). Over the past year, BMY's performance is -14.15%, compared to the S&P 500's 14.84% change.
According to market data, Bristol-Myers Squibb Company (BMY) stock's recent performance metrics show that over the last month, BMY is -8.84%, with a Year-to-Date (YTD) performance of -23.43%. Over the past year, the stock has seen a -14.15% change. These figures summarize BMY's price movements across various periods, reflecting its historical returns.
According to current financial data, BMY stock's P/E (TTM) ratio is 16.84, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for BMY, including P/S (1.92), P/B (5.25), and P/FCF (6.99), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.